Total: 2 |
|
PMID (PMCID) | ||
---|---|---|
25730142 |
MALE | Infant |
Necrotizing enterocolitis as an adverse effect of recombinant interleukin-2 and Ch14.18 in maintenance therapy for high-risk neuroblastoma. | ||
Levy G, Bonnevalle M, Rocourt N, Sudour H, Defachelles AS. J Pediatr Hematol Oncol. 2015;37(4):e250-2. |
||
Necrotizing enterocolitis as an adverse effect of recombinant interleukin-2 and Ch14.18 in maintenance therapy for high-risk neuroblastoma. | ||
25730142 |
MALE | Infant |
Necrotizing enterocolitis as an adverse effect of recombinant interleukin-2 and Ch14.18 in maintenance therapy for high-risk neuroblastoma. | ||
Levy G, Bonnevalle M, Rocourt N, Sudour H, Defachelles AS. J Pediatr Hematol Oncol. 2015;37(4):e250-2. |
||
We report an unusual case of necrotizing enterocolitis associated with the administration of interleukin-2 and ch14.18/CHO in maintenance therapy for localized NMyc amplified neuroblastoma (NBL). |